Left atrial enlargement and risk of ischemic stroke in elderly treated hypertensive patients

Sante D Pierdomenico1, Anna M Pierdomenico2, Silvio Di Carlo3

  • 1Dipartimento di Medicina e Scienze dell'Invecchiamento, Università Gabriele d'Annunzio, Chieti, Italy; Centro di Ricerca Clinica, Fondazione Università Gabriele d'Annunzio, Chieti, Italy. santedonato.pierdomenico@fastwebnet.it.

Insights

Left atrial enlargement independently predicts ischemic stroke risk in elderly hypertensive patients. This finding highlights the importance of monitoring atrial size for stroke prevention in this population.

Area of Science:

  • Cardiology
  • Neurology
  • Geriatrics

Background:

  • The prognostic value of left atrial enlargement in predicting ischemic stroke remains unclear.
  • Hypertension and aging are significant risk factors for stroke.

Purpose of the Study:

  • To investigate the association between left atrial enlargement and the risk of ischemic stroke.
  • To determine if left atrial enlargement is an independent predictor of ischemic stroke in elderly treated hypertensive patients.

Main Methods:

  • A cohort of 1,191 elderly treated hypertensive patients (60-90 years) was followed for a mean of 9.1 years.
  • Left atrial diameter was indexed to body surface area, with enlarged defined as ≥2.4 cm/m².
  • Cox regression analysis was used to assess the association between left atrial enlargement and ischemic stroke risk, adjusting for covariates.

Main Results:

  • 139 ischemic strokes occurred during follow-up.
  • Patients with enlarged left atria had a significantly higher incidence of ischemic stroke compared to those with normal left atria (P < 0.01).
  • Left atrial enlargement was independently associated with an increased risk of ischemic stroke (Hazard Ratio = 1.54; P = 0.03) after multivariable adjustment.

Conclusions:

  • Left atrial enlargement is an independent predictor of ischemic stroke in elderly treated hypertensive individuals.
  • Monitoring left atrial size may aid in risk stratification for ischemic stroke in this patient group.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K